Monday, May 15, 2017 11:06:05 AM
Perhaps three times over two years
Did he ever tell you he doesn't care about the share price?
No. He did emphasise that they don't run Nanologix based upon share price, but upon production needs and sales
Where do you think the CEO interest lies shareholders or himself?
My opinion? As he is the largest shareholder, his interests are ours
Do you really believe he would ever give up control of the company?
Again, in my opinion, I don't think he ever wanted to run Nanologix and I think he anticipates retiring once Nanologix achieves commercial success
Do you think that if he left the company, the technology will stay with the company or leave with him?
My opinion is that since the technology is licensed to Nanologix, that unless there was some nefarious action to force him to leave, the technology would stay. It could likely stay even in that event if agreements could be made to that end.
The important question.
Do you think he would ever gives up total control of technology to either license out or sell the company?
I don't understand the concept of the licensing out of technology by a 2-3 product penny stock company and then having the company stay in business. What sort of model for that would you envision? Would Nanologix then essentially become a Trust to distribute dividends? Licensing revenue versus direct sales revenue should have a vast gap in what Nanologix receives, with potential sales being much higher. What would Nanologix have left to sell with a licensing agreement? If they received 5%-6% license fee that would likely be the end of any operations.
The sale of the company could be a winner for us all
All in my opinion
EI
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM